Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-08-04

Clinical Trial Update: The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study assesses Zidovudine and Oxazepam when given alone and in combination in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXAZEPAM (OXAZEPAM)
  • Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED